FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1468-1469 November 4, 1999 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Schnitzler, M. A. PubMed Citation

With the discovery of cyclosporine and anti–T-cell antibodies and the successful application of HLA matching, short-term and long-term graft-survival rates for cadaveric kidney transplants have improved dramatically. Nonetheless, there are more than 40,000 people in the United States waiting for a kidney transplant, with an ever-widening gap between supply and demand. The organ shortage has fueled the ongoing debate about how cadaveric kidneys should be allocated. This frequently rancorous debate has pitted patient against patient, physician against physician, smaller hospitals against larger institutions, and politicians from states with large multiorgan-transplantation programs against those from states with smaller programs.

To address . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.